Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 13.93
+0.62 (4.66%)
At close: May 7, 2026
Laekna Market Cap
Laekna has a market cap or net worth of 5.6 billion as of May 7, 2026. Its market cap has increased by 40.81% in one year.
Market Cap
5.60B
Enterprise Value
4.33B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.93
Market Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 5.60B, a decrease of -4.34%. That is a compound annual growth rate of -1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 5.86B | 3.22% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 8.18B |
| CK Life Sciences Int'l., (Holdings) | 7.21B |
| Guangzhou Innogen Pharmaceutical Group | 6.08B |
| Ocumension Therapeutics | 5.78B |
| Jacobio Pharmaceuticals Group | 5.04B |
| Beijing Luzhu Biotechnology | 4.39B |
| Shandong Boan Biotechnology | 4.14B |
| Qyuns Therapeutics | 3.82B |